Picture of ViroGates A/S logo

VIRO — ViroGates A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: ViroGates Plans Reorganisation, Adjusts 2024 Guidance

Dec 17 (Reuters) - ViroGates A/S  VIROG.CO :
    * SAID ON MONDAY IT WILL REORGANISE ITS MARKETING, SALES
DEPARTMENT TO FOCUS ON LONGEVITY AND HEALTH SEGMENT
    * REVISES 2024 GUIDANCE 
    * NOW EXPECTS 2024 REVENUE BETWEEN DKK 4.5 AND 5 MLN
(PREVIOUSLY
DKK 4.5 AND 6 MLN)
    * EXPECTS 2024 EBIT OF DKK -14.5 TO -15.5 MILLION
(PREVIOUSLY DKK
-14 AND -15.5 MLN)
    * AS RESULT OF REORGANISATION, VIROGATES EXPECTS SOME
POSITIONS TO
BE MADE REDUNDANT
    * WILL SET ASIDE SEVERANCE COSTS IN 2024 FINANCIAL STATEMENT

        
 Source text for Workspace:  urn:newsml:reuters.com:*:nMFN1CJmHN
 Further company coverage:  VIROG.CO  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on ViroGates A/S

See all news